BRCA1 and neoplasm: However, we provide the first evidence to support the tumor mRNA expression levels of BRCA1 as predictive and prognostic marker in esophageal cancer with cisplatin- or docetaxel-based treatments and indicated the need to further validate in a large number of patients prospectively.